SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  For example, here is how to disable FireFox ad content blocking while on Silicon Investor.
Biotech / Medical : Trega Biosciences (TRGA), formerly HPIP

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: E.J. Neitz Jr who started this subject8/30/2000 10:58:31 AM
From: bob zagorin   of 152
 
Outsourcing of Early Discovery Chemistry Experiences to be Discussed By 7 Pharma Giants at Conference & Expo From October 25-27, Long Branch, NJ

LONG BRANCH, N.J., Aug. 30 /PRNewswire/ -- Early discovery chemistry outsourcing experiences will be discussed by the pharmaceutical giants Bristol-Myers Squibb, Pharmacia Corporation, SmithKline Beecham, Glaxo Wellcome, Pfizer Global Research, Ann Arbor Labs, and DuPont Crop Protection at "Outsourcing Discovery Chemistry & Chemical Development Services" in Long Branch, NJ, from October 25-27, announces Strategic Research Institute.

The meeting, the fourth in the series since July/99, will be broadly attended by the pharmaceutical, fine chemical, CRO, and biotech communities.

To register, please call 212.967.0095, x232; the fee is $1295.

To request additional information and/or book your hotel room, contact Anit Hora at ahora@srinstitute.com or 212-967-0095, x261. NO ROOM RESERVATIONS MAY BE MADE DIRECTLY BY CONTACTING THE HOTEL. Please include email and snail mail addresses to expedite your request.

The early discovery outsourcing talks are as follow:

-- Outsourcing Custom Synthesis Supporting Early Discovery

Mark Creswell, Pfizer Global Research, Ann Arbor Laboratories

-- Building a Collection of Novel, Non-Commercially Available Monomers by

Outsourced Custom Synthesis Duncan Judd, Glaxo Wellcome - UK

-- Technical Aspects of Outsourcing Combinatorial Chemistry

Mike Howard, DuPont Crop Protection

-- Procuring Compounds and Combinatorial Libraries from External Sources

Richard Thomas, Pharmacia Corporation

-- A Global Strategy to Develop a Primary Screening Deck

Michael Sofia, Bristol-Myers Squibb

-- Compound Acquisition: Where Have We Been & Where Do We Go Next?

David Langley, Glaxo Wellcome - UK

The early conference sponsor and exhibition list includes ChemFirst, Organix, Gateway Chemical, Array BioPharma, ArQule, MediChem Life Sciences, Camitro Corporation, Trega Bioscience, Engineered Tecnologies, Pharmacopeia, Peakdale Fine Chemicals, and CarboGen.

The full agenda is as follows:

-- Chemical Outsourcing Trends Panel Discussion: A View from The Street

Moderator, Stefan Loren, Legg Mason

-- Outsourcing Custom Synthesis Supporting Early Discovery

Mark Creswell, Pfizer Global Research, Ann Arbor Laboratories

-- Building a Collection of Novel, Non-Commercially Available Monomers by

Outsourced Custom Synthesis

Duncan Judd, Glaxo Wellcome - UK

-- Technical Aspects of Outsourcing Combinatorial Chemistry

Mike Howard, DuPont

-- The Novartis-Vertex Drug Discovery Collaboration

Roger Tung, Vertex Pharmaceuticals

-- The Pfizer - ArQule Drug Research & Technology Licensing Agreement

Sheila Dewitt, ArQule, Inc.

-- Outsourcing Natural Products Discovery: Biodiversity, Combinatorial

Biosynthesis and Libraries for Rapid Hit Prioritization & Lead

Identification, Steve Wrigley, Terragen, Inc. - UK

-- Procuring Compounds from and Combinatorial Libraries from External

Sources

Richard Thomas, Pharmacia Corporation

-- A Global Strategy to Develop a Primary Screening Deck

Mike Sofia, Bristol-Myers Squibb

-- External Compound Acquisition: Where Do We Go From Here?

David Langley, Glaxo Wellcome - UK

Panel on Intellectual Property

Moderated by Tom Saunders, Lorusso & Loud, Boston

-- Enhanced Innovation in Drug Discovery Through Chemical Outsourcing,

Kevin Koch, Array BioPharma

-- Outsourcing ADME/TOX/PK Assays

CEREP

-- The Whole Enchilada: Outsourcing of Proprietary Lead Discovery &

Optimization

Jonathan Burnbaum, Pharmacopeia

-- Outsourcing Chemistry to Pharma & Non-Pharma

Lew Makings, Aurora Biosciences

-- Outsourcing IT and Software Development to Accelerate Drug Discovery

Trevor Heritage, Tripos

-- Panel Discussion on Lead Discovery & Optimization

Moderated by Mike Howard, DuPont Crop Protection

Panelists: Oxford Asymmetry, Bristol-Myers Squibb, Hoffmann-La Roche,

Pfizer Global Research, Ann Arbor Laboratories, MediChem Life Sciences,

Glaxo Wellcome, Pharmacia Corporation

-- Implementing the Best Pharma - CRO Business Model

Moderator: John Budzinski, DuPont Pharmaceuticals

-- Case Study in Chemical Development Outsourcing

Abbott Laboratories

-- Outsourcing of Process Chemistry for Early Drug Candidates

Jolanta Nowakowski, Pfizer, Groton

-- Outsourcing of Bulk Actives: A Biotech Perspective

Jack Regan, Genentech

-- Panel on Outsourcing Chemical Development Services

Moderated by Michael Kolb, Wyeth Ayerst;

Panelists: Pfizer, Bristol-Myers Squibb, Merck & Company, Abbott Labs,

Schering Plough, Eli Lilly, Pharm-Eco Labs, Genentech

-- Outsourcing Process Research & Development at Eli Lilly

Thomas Eckrich, Eli Lilly & Company

QA Assurance and Chemical Development Outsourcing

Carl Rifino, AstraZeneca Pharmaceuticals

-- Small Company Outsourcing Manufacture of Final Product

Matt Hulbert, Cephalon

-- Chemical Outsourcing Regulatory (TBA)

SOURCE Strategic Research Institute

CO: Strategic Research Institute; Bristol-Myers Squibb; Pharmacia Corporation; SmithKline Beecham; Glaxo Wellcome; Pfizer Global Research; Ann Arbor Labs; DuPont Crop Protection

ST: New Jersey

IN: MTC

SU: TDS

08/30/2000 09:28 EDT prnewswire.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext